StockData
ENDRA Life Sciences Inc. logo

ENDRA Life Sciences Inc. (NDRA) stock

NDRANasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$4.04+0.12 (+2.93%)

Close on Nov 18, 2026Market cap $6.05MP/E –Yield –

ENDRA Life Sciences operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

ENDRA Life Sciences's operating income for the twelve months ending Jun 30, 2026 was -$6.65M. For fiscal 2025 it was -$5.76M. The highest annual figure on record is -$1.79M in fiscal 2016.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$5.76M–
FY2024Dec 31, 2024-$10.82M–
FY2023Dec 31, 2023-$10.52M–
FY2022Dec 31, 2022-$13.16M–
FY2021Dec 31, 2021-$11.50M–
FY2020Dec 31, 2020-$11.50M–
FY2019Dec 31, 2019-$10.84M–
FY2018Dec 31, 2018-$9.02M–
FY2017Dec 31, 2017-$4.63M–
FY2016Dec 31, 2016-$1.79M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.48M–
Q1 FY2026Mar 31, 2026-$2.17M–
Q4 FY2025Dec 31, 2025-$1.62M–
Q3 FY2025Sep 30, 2025-$1.37M–
Q2 FY2025Jun 30, 2025-$1.30M–
Q1 FY2025Mar 31, 2025-$1.47M–
Q4 FY2024Dec 31, 2024-$4.30M–
Q3 FY2024Sep 30, 2024-$1.51M–
Q2 FY2024Jun 30, 2024-$2.23M–
Q1 FY2024Mar 31, 2024-$2.78M–
Q4 FY2023Dec 31, 2023-$1.46M–
Q3 FY2023Sep 30, 2023-$3.13M–
Q2 FY2023Jun 30, 2023-$2.99M–
Q1 FY2023Mar 31, 2023-$2.94M–
Q4 FY2022Dec 31, 2022-$3.31M–
Q3 FY2022Sep 30, 2022-$3.42M–
Q2 FY2022Jun 30, 2022-$3.57M–
Q1 FY2022Mar 31, 2022-$2.86M–
Q4 FY2021Dec 31, 2021-$3.07M–
Q3 FY2021Sep 30, 2021-$2.65M–
Q2 FY2021Jun 30, 2021-$3.20M–
Q1 FY2021Mar 31, 2021-$2.58M–
Q4 FY2020Dec 31, 2020-$2.25M–
Q3 FY2020Sep 30, 2020-$3.26M–
Q2 FY2020Jun 30, 2020-$2.89M–
Q1 FY2020Mar 31, 2020-$3.10M–
Q4 FY2019Dec 31, 2019-$3.13M–
Q3 FY2019Sep 30, 2019-$2.64M–
Q2 FY2019Jun 30, 2019-$2.33M–
Q1 FY2019Mar 31, 2019-$2.75M–
Q4 FY2018Dec 31, 2018-$2.00M–
Q3 FY2018Sep 30, 2018-$2.36M–
Q2 FY2018Jun 30, 2018-$1.82M–
Q1 FY2018Mar 31, 2018-$2.84M–
Q4 FY2017Dec 31, 2017-$2.30M–
Q3 FY2017Sep 30, 2017-$910.93K–
Q2 FY2017Jun 30, 2017-$1.06M–
Q1 FY2017Mar 31, 2017-$360.70K–
Q4 FY2016Dec 31, 2016-$318.88K–
Q3 FY2016Sep 30, 2016-$605.11K–

More ENDRA Life Sciences figures

See a number that looks wrong?